Literature DB >> 9003436

Role of the amino terminal domain in GroES oligomerization.

O Llorca1, K Schneider, J L Carrascosa, E Méndez, J M Valpuesta.   

Abstract

Digestions of the GroES oligomer with trypsin, chymotrypsin and Glu-C protease from Staphylococcus aureus V8 (V8) have helped to locate three regions in the GroES sequence that are sensitive to limited proteolysis and have provided information of the GroES domains involved in monomer-monomer and GroEL interaction. The removal of the first 20 or 27 amino acids of the N-terminal region of each GroES monomer by trypsin or chymotrypsin respectively, abolish the oligomerization of the GroES complex and its binding to GroEL. The V8-treatment of GroES promotes the breakage of the peptide bond between Glu18 and Thr19 but not the liberation of the N-terminal fragment from the GroES oligomer, which is capable of forming with GroEL a complex active in protein folding. It is deduced from these results that the N-terminal region of the GroES monomer is involved in monomer-monomer interaction, providing experimental evidence that relates some biochemical properties of GroES with its three-dimensional structure at atomic resolution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003436     DOI: 10.1016/s0167-4838(96)00106-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

Review 1.  Assembly of chaperonin complexes.

Authors:  A R Kusmierczyk; J Martin
Journal:  Mol Biotechnol       Date:  2001-10       Impact factor: 2.695

Review 2.  Cpn20: siamese twins of the chaperonin world.

Authors:  Celeste Weiss; Anat Bonshtien; Odelia Farchi-Pisanty; Anna Vitlin; Abdussalam Azem
Journal:  Plant Mol Biol       Date:  2008-11-25       Impact factor: 4.076

3.  Biochemical evidence for relaxed substrate specificity of Nα-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis.

Authors:  Deepika Pathak; Aadil Hussain Bhat; Vandana Sapehia; Jagdish Rai; Alka Rao
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.